ClinicalTrials.gg
Not yet recruitingNCT07859657Updated Oct 6, 2026

Cardiovascular Alterations in Obese Children

An observational study in Pediatric Obesity, sponsored by Assiut University. Not yet recruiting. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by Assiut University · Observational

How we know

Updated Oct 6, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
150
Ages
1 Year to 18 Years
Sex
All
01

Study summary

This cross-sectional study aims to assess cardiovascular structural and electrophysiological alterations in obese children attending Assiut University Children's Hospital.

Read the detailed description

Childhood obesity is associated with early cardiovascular structural and electrophysiological changes. This observational study will evaluate left ventricular structure and function by echocardiography and electrocardiographic parameters including P-wave duration and dispersion in children and adolescents with obesity aged 1 to 18 years.

02

Conditions studied

  • Pediatric Obesity

Keywords

  • Obesity
  • Echocardiography
  • Electrocardiography
  • Left ventricular mass
  • P-wave dispersion
  • Assiut
  • Children
03

In context

Pediatric Obesity

1,132 studies on the registry are indexed under Pediatric Obesity; 183 are open to participants now.

This study's planned enrollment of 150 is below the median of 179 across 236 observational studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

Assiut University is the lead sponsor of 5,094 studies on the registry; 2,187 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children and adolescents aged 1 to 18 years with obesity (BMI ≥95th percentile for age and sex) attending Assiut University Children's Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • - Age 1 to 18 years
  • ≥95th percentile for age and sex
  • No previously diagnosed structural heart disease
  • No known primary cardiac rhythm or conduction disorder
  • Written from parent or legal guardian

Exclusion criteria

Exclusion Criteria:

  • - Known structural heart disease
  • Known cardiac arrhythmia or conduction abnormality
  • Diabetes mellitus
  • Hypertension requiring treatment
  • Hypothyroidism or other endocrine disorders affecting cardiac function
  • Chronic renal, hepatic, respiratory, or systemic disease
  • Pulmonary hypertension
  • Obstructive sleep apnea
  • Medications known to affect cardiac rhythm or function
  • Electrolyte abnormalities
  • Acute significant illness at the time of assessment
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Obese Children

    Children and adolescents aged 1 to 18 years with body mass index ≥95th percentile for age and sex attending Assiut University Children's Hospital.

06

What researchers measure

Primary outcomes

  1. Mean left ventricular mass index

    Mean left ventricular mass index measured by echocardiography in g/m².

    Time frame: Baseline

Secondary outcomes

  1. Mean P-wave dispersion

    Mean P-wave dispersion measured on 12-lead electrocardiogram in milliseconds.

    Time frame: Baseline

  2. Mean corrected QT interval

    Mean corrected QT interval (QTc) measured on 12-lead electrocardiogram in milliseconds.

    Time frame: Baseline

  3. Mean E/A ratio

    Mean early to late diastolic filling velocity ratio (E/A ratio) measured by pulsed-wave Doppler echocardiography.

    Time frame: Baseline

  4. Mean left ventricular wall thickness

    Mean left ventricular wall thickness measured by echocardiography in millimeters.

    Time frame: Baseline

  5. Mean body mass index

    Mean body mass index in kg/m².

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Oct 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2026
First posted
Oct 6, 2026
StartEst.
Oct 2, 2026
Primary completionEst.
Oct 10, 2027
CompletionEst.
Mar 1, 2028
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07859657
Lead sponsor
Assiut University
Responsible party
Mohamed Ahmed Mohamed Hussein (Resident Physician, Department of Pediatrics, Assiut University) — Principal investigator
First posted
Oct 6, 2026
Start date
Oct 2, 2026 (estimated)
Primary completion
Oct 10, 2027 (estimated)
Completion
Mar 1, 2028 (estimated)
Last update
Oct 6, 2026

Study contacts

Mohamed A Mohamed, Resident
Contact
mohamedmnr949@gmail.com
+20 10 30046583
Faisel E Ahmed, prof
study chair · Pediatrics Department, Assiut University Hospitals

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion